Completed clinical trials

Completed clinical trials

Study (Acronym) & Study TypeSponsor/ClientStudy Director/SDPStaff (IBE)
ACEI-COVID: Stopping ACE-inhibitors in COVID-19: A Randomized Controlled TrialMed. University InnsbruckPD Dr. K. Rizas
Prof. Dr. S. Massberg
Prof. Dr. U. Mansmann
ACUZoster: Phase III: Optimization of Treatment for Herpes ZosterLMU HospitalPD Dr. D. Irnich
(Schmerzambulanz)
NN
ALCAT: Efficacy of Acetyl-DL-Leucine in Patients with Cerebellar Ataxia: A Randomized, Double-Blind, Placebo-Controlled, Phase III Crossover StudyLMU Hospital - DSGZProf. Dr. M. StruppDr. C. Adrion
ALTERNATIVE: A chemotherapy-free combination of the Bruton's Tyrosine Kinase Inhibitor, Ibrutinib in combination with GA 101 in patients with previously untreated follicular lymphoma and a high tumor burdenLMU Hospital - Med IIIProf. Dr. M. DreylingProf. Dr. E. Hoster
Dr. V. Jurinovic
APPROACH: Apixaban versus Phenprocoumon: Oral anticoagulation plus antiplatelet therapy in patients with acute coronary syndrome and atrial fibrillationLMU Hospital - Med IPD Dr. R. WakiliDr. A. Crispin
ArthroMark: Biomarkers and imaging for diagnosis, monitoring and stratification of rheumatoid arthritis and spondyloarthritidesCharité BerlinProf. Dr. G. BurmesterLien Le
BEMED: Treatment of Meniere's Disease with Betahistine—A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Finding StudyLMU Hospital - DSGZProf. Dr. M. StruppDr. C. Adrion
BETAVEST: Effects of Betahistine on Central Vestibular Compensation in Acute Unilateral Vestibulopathy: A Double-Blind, Placebo-Controlled Clinical TrialLMU Hospital - DSGZ

Prof. Dr. M. StruppDr. C. Adrion
BMP2: Phase III: Bone Formation During Spinal FusionBG Hospital HalleProf. Dr. HJ Meisel (Halle)Prof. Dr. U. Mansmann
BMS-Studienvergleich: Comparative Analysis of DASISION with ENESTndBristol-Myers SquibbDr. I. AbrahamProf. Dr. M. Pfirrmann
BODO: Multicenter, open-label single arm phase II study testing the tolerability and the efficacy of Bosutinib step-in dosing in Chronic Phase CML patients intolerant or refractory to previous Nilotinib or Dasatinib therapyRheinische Friedrich-
Wilhelms-University of Bonn
/ University Hospital RWTH Aachen
Prof. Dr. D. Wolf
Prof. Dr. T. Brümmendorf
Prof. Dr. M. Pfirrmann
BreathEase: Randomised controlled trial testing the effectiveness of a new multi-professional Breathlessness service for patients with any advanced disease against usual careLMU HospitalProf. Dr. C. BauseweinProf. Dr. U. Mansmann
Ceprotin: Case Report: Use of CEPROTIN in Purpura FulminansBaxterDr. A. Veldmann (Dept. of Pediatrics, Monash University, Melborne, AU)Prof. Dr. U. Mansmann
CHART: Phase IV: Comparison of 6% Hydroxyethyl Starch and 5% Albumin for Volume Replacement Therapy in Patients Undergoing CystectomyLMU HospitalProf. Dr. B. Zwißler
Prof. Dr. M. Rehm (Anästhesiologie)
Dr. A. Crispin
CML 2004 IMATINIB #068: Treatment of CML patients with Imatinib + hydroxyurea - A phase I/II studyLeipzig University HospitalProf. Dr. D. Niederwieser
Prof. Dr. T. Lange
Prof. Dr. M. Pfirrmann
CML IV: A randomized controlled trial comparing imatinib vs. imatinib plus interferon α vs. imatinib plus low-dose AraC vs. imatinib following failure of interferon α, with an evaluation of the role of allogeneic stem cell transplantation in newly diagnosed CML in the chronic phaseUniversity Hospital MannheimProf. Dr. R. HehlmannPD Dr. M. Lauseker-Hao
CML V - TIGER: Treatment optimization of newly diagnosed Ph/BCR-ABL positive
patients with chronic myeloid leukemia (CML) in chronic phase with nilotinib vs. nilotinib plus interferon alpha induction and nilotinib or interferon alpha maintenance therapy
Friedrich-Schiller-University JenaProf. Dr. A. HochhausProf. Dr. M. Pfirrmann
T. Brenninger-Lang
D. Kohn
CoSeal: The Use of Fibrin Glue in Lung SurgeryUniversity RomeA. D'Andrilli, M.D. (Dep. of Thoracic Surgery, Roma, La Sapienza, IT)Prof. Dr. U. Mansmann
DasaHIT: Treatment optimization for patients with CML receiving first-line therapy and patients with resistance to or intolerance of alternative BCR-ABL tyrosine kinase inhibitors (≥second line)Friedrich-Schiller-University JenaProf. Dr. A. HochhausProf. Dr. M. Pfirrmann
Decline: matinib 400 mg daily versus Nilotinib 300 mg twice daily in patients with chronic myeloid leukemia (CML) in 1st chronic phase and confirmed major mo-lecular response (MMR) receiving Imatinib at a dose of 400 mg dailyUniversity Hospital FreiburgProf. Dr. N. von BubnoffProf. Dr. U. Mansmann
Dentsply: Dentistry, Evaluation of the Clinical Performance of ChemFil™RockDentsply DeTraywiss. Berater: Prof. Dr. R. Hickel (Zahnerhaltung/ Paradontologie, KUM)Prof. Dr. U. Mansmann
DepressionDC: Electrostimulation for Chronic DepressionHospital LMU - Hospital for PsychiatryProf. Dr. F. PadbergDr. A. Crispin

EAT2TREAT: Pharmacological therapy of EA2:
a placebo-controlled comparison of the efficacy of 4-AP and acetazolamide
LMU Hospital - DSGZProf. Dr. M. StruppProf. Dr. U. Mansmann
EMPN: Prospective, multicentre observational study to integrate clinical data with genomic investigations with the aim of providing a shared resource of information on epidemiology, genetics, and prognosis of myeloproliferative neoplasmsUniversity HeidelbergProf. Dr. A. ReiterA. Albeer
Prof. Dr. M. Pfirrmann
EMVERT: Is it stroke? Developing a diagnostic index test to identify stroke as cause of vertigo, dizziness, and imbalance in the emergency roomLMU Hospital - DSGZProf. Dr. K. JahnDr. I. Ricard
ENDURE: fficacy and Safety of Ro-PEG-IFN in Maintaining Deep Molecular Remission in Patients with CML Who Discontinue Treatment with an ABL Kinase InhibitorUniversity MarburgProf. Dr. A. BurchertProf. Dr. M. Pfirrmann
EORTC 62961/ ESHO RHT-95: Phase III: Hyperthermia for Soft Tissue SarcomasEORTCProf. Dr. R. Issels (Med. III, Hyperthermie)R. Laubender
ERIC: Enhanced Recovery after Intensive CareCharité BerlinProf. Dr. C. D. SpiesDr. C. Adrion
EschQol: Study on the Health Economics and Quality of Life of
Hemophilia Patients
LMU HospitalProf. Dr. W. Schramm (Transfusionsmed./ Hämostaseologie)Prof. Dr. U. Mansmann
Evaluation RECIST: Randomized clinical trial, Phase IIIMerckProf. Dr. U. MansmannR. Laubender
FACEG: Effect of 4-aminopyridine-SR on gait and falls in cerebellar ataxia - a monocenter, randomized, double-blind, placebo-controlled, 2-way crossover phase II trialLMU Hospital - DSGZProf. Dr. K. JahnDr. A. Crispin
FAM: Observational StudyUniversity Hospital BonnProf. Dr. F.G. HolzProf. Dr. U. Mansmann
Strengthening and Protecting Families—Dealing with Familial Colorectal Cancer: A registry study combined with an observational studyFederal Ministry for Family, Senior Citizens, Women, and YouthProf. Dr. U. MansmannProf. Dr. U. Mansmann
FARKOR: Screening for Colorectal Cancer in Individuals with a Family History of the DiseaseInnovation Fund Friedrich Burda FoundationProf. Dr. U. Mansmann
D. Lindörfer
Dr. A. Crispin
Dr. S. Hoffmann
FIRM-ACT: Randomized Trial to Optimize Treatment for Adrenocortical TumorsCollaborative group for adrenocortical Carcinoma Treatment (CO-Act)Prof. Dr. B. Skogseid
(UK Uppsala, SWE)
Prof. Dr. H.H. Müller
Fr1da: Intervention Study on the Early Detection and Treatment of Children with Type 1 DiabetesHelmholtz-Center MunichProf. Dr. A. G. ZieglerProf. Dr. M. Pfirrmann
FSME: Phase III: Expansion of the vaccine's approvalBaxterProf. Dr. R. Kaiser (Klinikum Pforzheim)
PD. Dr. R. Schosser (Baxter)
Prof. Dr. U. Mansmann
GERMAIN: Phase II study of Bortezomib, Melphalan, Prednisone (VMP) followed by Lenalidomide maintenance vs. VMP without maintenance in Myeloma patients not eligible to high-dose chemotherapy and autologous stem cell transplantation – a GERman MAINtenance studyFriedrich-Schiller-University JenaPD Dr. A. BrioliProf. Dr. M. Pfirrmann
HEAD: Phase III: Therapieoptimierung von Kindern mit BECTSLMU HospitalProf. Dr. F. Heinen (Dr. von Haunersches Kinderspital)Prof. Dr. U. Mansmann
HEAT: Phase III: Optimizing Treatment for Children with BECTSLMU Hospital - Med III/ HyperthermieProf. Dr. R. IsselsProf. Dr. U. Mansmann
Dr. Y. Xu
HEAT 2nd line
(former HEAT Pilot): Pilot Phase: Optimizing Treatment
for Pancreatic Cancer
LMU HospitalProf. Dr. R. Issels (Med. III/ Hyperthermie)Prof. Dr. U. Mansmann
Helicobacter-Studie: Diagnostic StudyLMU HospitalProf. Dr. R. Haas (Max von Pettenkofer-Institut)Prof. Dr. U. Mansmann
HPE1: Case ReportTravaCareDr. A. CrispinProf. Dr. U. Mansmann
HTCR: Renovation of a Biomaterial BankStiftung HTCR (Human Tissue & Cell Research)PD Dr. W. Thasler (Chirurgische Klinik)Dr. T. Müller
ILOCARD:Phase III: Improving Respiratory Function During Cardiac SurgeryLMU HospitalProf. Dr. B. Zwißler (Anästhesiologie)Prof. Dr. H.H. Müller
INTESTA1: The Effect of Perioperative Antioxidants and Glutamine on Postoperative Immunosuppression and SIRS ActivityLMU HospitalProf. Dr. KW Jauch (Chirurgie)Prof. Dr. U. Mansmann
JointConEval: Effectiveness of a complex intervention to improve social participation in nursing home residents with joint contractures: study protocol of a multicentre clusterrandomised controlled trialLMU
TH Rosenheim
MLU Halle
Prof. Dr. U. Mansmann
Prof. Dr. M. Müller
Prof. Dr. G. Meyer
Prof. Dr. U. Mansmann
Lien Le
Koloskopie-Screening: Diagnostic StudyLMU HospitalProf. Dr. F. Kolligs
Prof. Dr. B. Göke (Med.II)
Dr. A. Crispin
KOPFregister: Observational Study: Coma Outcomes in Patients Undergoing Early Neurological RehabilitationLMU HospitalPD Dr. A. BenderProf. Dr. E. Grill
MAURITIUS: Midostaurin in MRD-positive acute myeloid leukemia after allogeneic stem cell transplantationFriedrich-Schiller-University JenaProf. Dr. S. SchollDr. C. Adrion
Men-C: Study on Meningococcal Vaccination CoverageBaxterProf. Dr. R. von Kries (Soz. Pädiatrie und Jugendmedizin, LMU)Prof. Dr. U. Mansmann
MICA: Apharese-Studie; Phase II, monocenter, prospective, randomized, controlled trialLMU HospitalProf. Dr. K.G. Parhofer
(Med. II)
Dr. A. Crispin
MobilE-PHY2: Effectiveness of an evidence-based care pathway to improve mobility and participation in older patients with vertigo and balance disorders in primary care: multicentre cluster-randomised controlled trialFederal Ministry of Education and ResearchProf. Dr. U. Mansmann
Prof. Dr. M. Müller
Dr. A. Crispin
MUKIS: Munich Study on Headaches Among High School Students - Intervention StudyLMU HospitalProf. Dr. R. von Kries (Soz. Pädiatrie und Jugendmed.)
Prof. Dr. F. Heinen (iSPZ)
Prof. Dr. A. Straube (Neurologie)
Prof. Dr. U. Mansmann
NASPOCAD: Effect of Combined Therapy with Niacin and Statins in Coronary Heart DiseaseLMU HospitalProf. Dr. W.M. Franz
(Med. I, Kardiologie)
Prof. Dr. U. Mansmann
PASTURE: Protection against Allergy: Study in Rural EnvironmentsLMU HospitalProf. Dr. E. von Mutius (Haunersche Kinderklinik, LMU München)Dr. T. Müller
PINGUIN: A phase II, randomized, double-blind, 2-arm controlled study to evaluate efficacy of the DPPIV-inhibitor Vildagliptin for prevention of type 2 diabetes in women with a recent history of insulin-requiring gestatinal diabetesHelmholtz Center
Munich
Dr. M. Walter
Prof. Dr. A.-G. Ziegler
Prof. Dr. M. Pfirrmann
Piz Palue: Survey on Fear of HeightsLMU Hospital - DSGZProf. Dr. T. BrandtDr. A. Crispin
PK-BeST: Pharmacokinetic profile of betahistine blood concentration with and without selegiline: A mono-center, controlled, open-labeled, pharmacokinetic, phase I trial in healthy volunteersLMU Hospital - DSGZProf. Dr. M. StruppDr. A. Al Tawil
PRÄP-GO: Prehabilitation for Older Patients with Frailty Syndrome Prior to Elective SurgeryCharité BerlinProf. Dr. C. D. SpiesProf. Dr. U. Mansmann
Dr. V. Loidl
PROMESA: Phase III: Effect of EGCG supplementation on disease progression of patients with Multiple System Atrophy (MSA) (Double blind, randomised, prospective placebo controlled parallel group study)LMU HospitalDr. J. Levin (Neurologie, LMU), Prof. Dr. G. Höglinger (DZNE, Neurologie TUM)Dr. I. Ricard
PROSPERA: Phase III: Optimization of Treatment for Progressive Supranuclear Palsy (PSP)LMU HospitalProf. Dr. S. Lorenzl (Palliativmedizin)Dr. A. Crispin
PROVEMIG: Prophylactic Treatment of Vestibular Migraine with Metoprolol: A Double-Blind, Placebo-Controlled StudyLMU Hospital - DSGZProf. Dr. M. StruppDr. C. Adrion
RAPS: Risk-Adapted Prevention Strategies for Colorectal CancerDKFZ HeidelbergProf. Dr. H. BrennerProf. Dr. U. Mansmann
R-HAD: Efficacy and safety of Rituximab, high-dose Ara-C and Dexamethasone (R-HAD) alone or in combination with Bortezomib in patients with relapsed or refractory mantle cell lymphomaLMU Hospital - Med IIIProf. Dr. M. DreylingProf. Dr. E. Hoster
L. Jiang
SASSICAIA: Strategies of loading with Prasugrel versus Clopidogrel in PCI-treated biomarker negative anginaLMU HospitalProf. Dr. J. Mehilli
(Med. I)
Dr. I. Ricard
SBK-Rückenschmerz: Observational Study on Back PainSBKPD Dr. D. Irnich (Schmerzambulanz)
Prof. U. Mansmann
M. Simang
SITAGRAMI: hase III: Recovery from a Myocardial InfarctionLMU HospitalProf. Dr. W.M. Franz
(Med.I, Kardiologie)
Prof. Dr. U. Mansmann
SMART-MI: Implantable cardiac monitors in high-risk post-infarction patients with cardiac autonomic dysfunction and moderately reduced left ventricular ejection fractionLMU Hospital - Med IProf. Dr. A. BauerDr. A. Al Tawil
SPACE II: Observational Study: Stent Comparison Following a Heart AttackUniversity Hospital HeidelbergProf. Dr. W. Hacke
(UK Heidelberg)
Prof. Dr. H.H. Eckstein (Gefäßchirurgie, TU München)
Prof. Dr. U. Mansmann
TEAM: Evidence of Effectiveness: Participation-Oriented Outpatient InterventionLMU HospitalPD Dr. A. Bender (Neurologische Klinik, LMU; TZ Burgau)Prof. Dr. U. Mansmann
TravaCare (HPE2): Observational Study on Home Parenteral NutritionB. Braun TravaCare(TravaCare)Dr. A. Crispin
Treat SVDs: Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases: a multicentre, open-label, randomised, crossover trialLMU HospitalProf. Dr. M. Dichgans
PD Dr. A. Kopczak
Prof. Dr. U. Mansmann
TRIKI: Evaluation of Trigger Points in Tension-Type Headaches in ChildrenLMU HospitalProf. Dr. F. Heinen (Dr. von Haunersches Kinderspital)Dr. V. Henschel
TRINITY: A multicenter, randomized, double-blind, placebo-controlled TRial evaluating Immunosuppressive treatment in patients with chronic virus-Negative Inflammatory cardiomyopaThYLMU Hospital - Med IPD Dr. U. GrabmaierDr. A. Crispin
Vasovist1: Diagnostic Study: Improving Artery Visualization (Phase IIa)LMU HospitalPD Dr. S. Schönberg (Radiologie)Prof. Dr. U. Mansmann
Vasovist2:Diagnostic Study: Improving Artery VisualizationLMU HospitalPD Dr. A. Huber (Radiologie)Prof. Dr. U. Mansmann
VesPa: Prophylactic treatment of vestibular paroxysmia with carbamazepine: a prospective, randomized, placebo-controlled, crossover, bi-centre trialLMU Hospital- DSGZProf. Dr. M. Strupp
Prof. Dr. M. Dieterich
Dr. I. Ricard
VitD@BPPV: Secondary prophylactic treatment of benign paroxysmal positioning vertigo (BPPV) with vitamin D - a prospective randomized placebo-controlled two-arm multicenter trialLMU Hospital- DSGZProf. Dr. M. Strupp
Prof. Dr. M. Dieterich
Dr. I. Ricard
Zweit-MeinungLMU HospitalDr. U. Berger